Federal contract

Department of Veterans Affairs awarded Johnson & Johnson: $19K obligated to date

Signed Oct 9, 2025 · Updated Oct 9, 2025

Johnson & JohnsonJNJ

$19K
committed so far

Why it stands out

The Department of Veterans Affairs has already agreed to pay Johnson & Johnson $19K. The job runs until Oct 10, 2025.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordUSAspending.gov — Prime award record

All the details

Dates, kept separate

Date signed: Oct 9, 2025
Reporting period: Not applicable
Last updated on USAspending: Oct 9, 2025

Veterans AffairsDelivery OrderEarliest mapped awardSubsidiary mapping

Context

Current obligations

$18,804

Actual federal dollars obligated to date on this award

Potential / ceiling value

$18,804

A maximum, not earned revenue

T12M mapped awards

$2.93M across 16 awards

Obligations to date on awards newly signed in the last 12 months, mapped to this company

Agency concentration

71% from the largest awarding agency

Share of T12M mapped obligations

Historical significance

Earliest mapped award on record

Within the awards OQRO has ingested

Scale vs annual revenue

0.00% of FY2022 revenue ($78.7B)

T12M mapped obligations ÷ revenue the company reported in its 10-K. A size comparison: obligations are not revenue and are usually earned over several years

Company mapping

verified alias

Exact identifier > verified alias > manual override

Source receipt

Record ID: CONT_AWD_36C24526N0094_3600_36F79724D0176_3600
Filed / recorded: Oct 9, 2025, 12:00 AM UTC
Added to OQRO: Oct 2, 2026, 3:59 AM UTC
Parser: usaspending-v1
Data quality: Read from the record; company matched by name
Award ID (PIID): 36C24526N0094
USAspending award key: CONT_AWD_36C24526N0094_3600_36F79724D0176_3600
Award type: DELIVERY ORDER
Recipient: JANSSEN BIOTECH INC
Recipient UEI: NVYMGFA53MN7
Parent recipient: JOHNSON & JOHNSON
Parent UEI: F78LUT6M7HL6
Awarding agency: Department of Veterans Affairs
Awarding sub-agency: Department of Veterans Affairs
Description: BALVERSA 4 MG
Date signed: Oct 9, 2025
Period of performance: Oct 9, 2025 – Oct 10, 2025
Last modified: Oct 9, 2025
NAICS: 325412 — Pharmaceutical Preparation Manufacturing
PSC: 6505
Pricing: FIRM FIXED PRICE
Mapping basis: Parent recipient “JOHNSON & JOHNSON”

Around the same time

12mo ago

22KShares · @ $157.92

Derivative exercise or conversion — not an open-market buy.

Why it stands out Official record

Officer sold12mo ago

~$4.19MReported value · 22K sh @ $192.7072

32K → 11K shares held−67% of their stake

Johnson & Johnson's Innovative Medicine, R&D sold $4.19M of Johnson & Johnson shares. Nobody planned it ahead of time.

Why it stands out Official record

12mo ago

22KDerivative units · @ $157.92

Derivative exercise or conversion — not an open-market buy.

Why it stands out Official record

Why it stands out

Dates, kept separate

Context

Source receipt

Around the same time

22KShares · @ $157.92

~$4.19MReported value · 22K sh @ $192.7072

22KDerivative units · @ $157.92

Most active this month